Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new footer line 'Revision: v3.6.5' has been added. The text items 'clinical study report synopsis', 'AbbVie', 'Helpful Links Provided by', and the previous 'Revision: v3.6.4' have been removed.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.6.4 replaces the previous Revision: v3.6.3 on the page. This appears to be a backend/UI update and does not modify study data or visible page content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a small site update. The study details and other content remain unchanged.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of v3.6.0, indicating a minor update to the page template. This update does not affect the study details or the information presented to users.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page adds new help/navigation items (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision tag to v3.6.0, while the previous label 'Intervention / Treatment' was removed and replaced with 'Intervention/Treatment'.SummaryDifference0.5%

- Check81 days agoChange DetectedThe revision tag in the page footer was updated from v3.5.4 to v3.5.5, indicating a minor software update to the page.SummaryDifference0.1%

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.